changing your setting. We'll assume that you are happy to receive all cookies on the BTG website.
The EKOS™ Control Unit PT3b with Acoustic Pulse Thrombolysis™ treatment is very unique. It uses targeted ultrasonic waves in combination with clot-dissolving drugs. The system uses a sophisticated catheter and an ultrasonic core to effectively target an entire clot.
The EKOS™ Control Unit PT3b with Acoustic Pulse Thrombolysis™ technology thins a clot’s fibrous mesh called fibrin. The acoustic pulse field makes the fibrin more porous while creating a pressure gradient which transports the clot-dissolving drug deep inside the clot.